Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Axsome Therapeutics, Inc. (NASDAQ: AXSM)
AXSM Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
51%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
4%
AXSM Stock Analysis
AXSM
PE Ratio:
AXSM
PEG Ratio:
Not Available
AXSM
Forward EPS Growth (12 month):
0.00%
AXSM
PS Ratio:
17
AXSM
PSG Ratio:
0.3
AXSM
Forward Revenue Growth (12 month):
65.10%
AXSM Articles
No data was found